Brain Lymphoma

Without treatment, patients with primary brain lymphoma may survive for less than 2 months. Patients who are treated with chemotherapy often survive 3 – 4 years or more, depending on whether the tumor stays in remission. About 40% of patients are alive at 5 years. Survival may improve with the increased use of autologous stem cell transplants.

Many factors including the health, age and condition of the immune system of the patient can affect treatment choices. Along with medical standard-of-care treatments, NSPC participates in a number of clinical trials, to offer you the most advanced treatment options available.

Corticosteroids may be given to reduce swelling and provide symptom relief.

Chemotherapy, which penetrates the blood-brain barrier and reaches the fluid surrounding the brain, might be given intravenously or intrathecally (directly into the fluid surrounding the spinal cord.)

Whole-brain radiation may be used if the lymphoma is resistant to chemotherapy.

Neurosurgery. Some larger well-defined lesions that are closer to the surface of the brain may be operable.

Autologous stem cell transplant uses the patient’s own stem cells for treatment.

Find out what revolutionary treatment options are available to you in the New York area. Contact one of our specialists at The Long Island Brain Tumor Center, NY.

Long Island Brain and Spine Tumor Center

NSPC provides state-of-the-art treatment of benign and malignant brain and spine tumors, using minimally invasive procedures like Gamma Knife®, Novalis TX™, and CyberKnife® rather than major surgery whenever appropriate. Our physicians also perform experienced pediatric neurosurgery — they give personalized, individual attention combined with knowledge and experience to take on the most challenging of cases.